Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
NCT01533051 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-05-08
Summary
The aim of this study is to investigate the off-treatment sustained virological and biochemical response in chronic hepatitis B patients following the guideline by the Asian Pacific Association for the Study of the Liver (APASL) in Korea.
Conditions
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
Sang Hoon Ahn, MD, PhD · Department of Internal Medicine, Yonsei Universtiy College of Medicine
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2015-03-31
- Completion
- 2016-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
NCT01205165 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
NCT00403585 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
NCT05661786 ·Status: RECRUITING
-
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544 ·Status: COMPLETED
-
Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care
NCT04904900 ·Status: RECRUITING
-
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
NCT02412592 ·Status: UNKNOWN
-
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Treatment and Prognosis of Patients With Chronic HBV Infection
NCT05392387 ·Status: RECRUITING
-
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
NCT04264312 ·Status: COMPLETED
-
Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function
NCT02267473 ·Status: UNKNOWN
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
NCT03519113 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
NCT03625102 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
NCT04028856 ·Status: COMPLETED
-
Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy
NCT01595633 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
NCT01928511 ·Status: COMPLETED ·Phase: PHASE4
-
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
NCT03013556 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels
NCT04780204 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
NCT06779864 ·Status: RECRUITING
-
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
NCT06041022 ·Status: UNKNOWN
-
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
NCT05957380 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
NCT02956850 ·Status: COMPLETED ·Phase: PHASE1
-
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711 ·Status: RECRUITING ·Phase: EARLY_PHASE1